NCT07065708 Transperineal Ultrasound as a Biofeedback Tool for Pelvic Floor Muscle Therapy in Postpartum Patients
| NCT ID | NCT07065708 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Singapore General Hospital |
| Condition | Pelvic Floor Muscle Training |
| Study Type | INTERVENTIONAL |
| Enrollment | 94 participants |
| Start Date | 2025-05-20 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 94 participants in total. It began in 2025-05-20 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Regular and effective pelvic floor muscle exercises after vaginal birth are crucial in reducing the risk of pelvic floor disorders in women. Pelvic floor muscle exercises are generally encouraged by healthcare providers to their patients after birth. However, it is often difficult to confirm whether a patient is performing pelvic floor muscle contractions correctly. A supervised pelvic floor physiotherapy session allows a professional to assess the pelvic floor and give their verbal feedback to patients. However even in this setting, patient's are reliant on the physiotherapist and have no way to assess their own performance. The 'biofeedback approach' allows for the clinician and patient to visually assess and modify their performance and can potentially allow for more effective therapy and better engagement. Transperineal ultrasonography is a widely available, safe and non-invasive biofeedback tool that can used at the bedside in order to assess pelvic floor muscle contractions. Our aim is to assess if using transperineal ultrasound can enhance the ability of postpartum patients to perform effective pelvic floor muscle therapy.
Eligibility Criteria
Inclusion Criteria: * Female participants * Aged 21 - 45 years old. * Within 4 months of a singleton, vaginal delivery Exclusion Criteria: * Currently pregnant * Over 4 months since vaginal birth. * Previous caesarean delivery. * Previous pelvic floor surgery (eg. pelvic floor repair, continence surgery, cervicetomy,cosmetic pelvic floor procedures) * Neurological disorder affecting muscle contraction (eg. Guillan-Barre syndrome, motorneuron disease, multiple sclerosis)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07065708 clinical trial?
This trial is open to female participants only, aged 21 Years or older, up to 45 Years, studying Pelvic Floor Muscle Training. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07065708 currently recruiting?
Yes, NCT07065708 is actively recruiting participants. Contact the research team at rahim.asad.abdul@sgh.com.sg for enrollment information.
Where is the NCT07065708 trial being conducted?
This trial is being conducted at Singapore, Singapore.
Who is sponsoring the NCT07065708 clinical trial?
NCT07065708 is sponsored by Singapore General Hospital. The trial plans to enroll 94 participants.